BusinessPhoto: Amar BusinessBiocon Receives Rs 3.2 Crore GST Notice; FDA to Hear Misleading Ads Case
Biocon Limited received a GST notice exceeding Rs 3.2 crore for FY 2022-23 from the GST office in Visakhapatnam-2, Andhra Pradesh. The notice includes Rs 1.85 crore GST, Rs 1.17 crore interest, and Rs 18.52 lakh penalty. Allegations involve non-submission of SEZ endorsement documents and irregularities in input tax claims. Biocon plans to appeal. Meanwhile, Maharashtra FDA received responses from actors on misleading ads and will hold further hearings.
Amar Business··Visakhapatnam


